HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute generalized exanthematous pustulosis associated with terbinafine: a case report.

Abstract
A 27-year-old male patient who has used oral terbinafine for two weeks was admitted to our outpatient clinic for non-follicular millimetric pustules on erythematous and edematous different-sized plaques on his trunk and flexural areas. He was diagnosed with acute generalized exanthematous pustulosis (AGEP) because of terbinafine use in the light of history, clinical and histopathological findings. An AGEP is a rare and severe pustular reaction usually triggered by systemic drug intake. Approximately, 2.3% of the patients having oral terbinafine have been reported to develop cutaneous adverse effects. Although terbinafine is a commonly used medicine, it must be considered that it may cause severe adverse reactions.
AuthorsHakan Turan, Ersoy Acer, Havva Erdem, Esma Uslu, Cihangir Aliagaoglu
JournalCutaneous and ocular toxicology (Cutan Ocul Toxicol) Vol. 32 Issue 4 Pg. 325-6 (Oct 2013) ISSN: 1556-9535 [Electronic] England
PMID23432048 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antifungal Agents
  • Naphthalenes
  • Terbinafine
Topics
  • Acute Generalized Exanthematous Pustulosis (etiology, pathology)
  • Adult
  • Antifungal Agents (adverse effects)
  • Humans
  • Male
  • Mucous Membrane (pathology)
  • Naphthalenes (adverse effects)
  • Skin (pathology)
  • Terbinafine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: